The evidence is in: Repetitive transcranial magnetic stimulation is an effective, safe and well-tolerated treatment for patients with major depressive disorder
- PMID: 34459284
- DOI: 10.1177/00048674211043047
The evidence is in: Repetitive transcranial magnetic stimulation is an effective, safe and well-tolerated treatment for patients with major depressive disorder
Erratum in
-
Erratum to "The evidence is in: Repetitive transcranial magnetic stimulation is an effective, safe and well-tolerated treatment for patients with major depressive disorder".Aust N Z J Psychiatry. 2023 Jun;57(6):927. doi: 10.1177/00048674221118794. Epub 2022 Aug 3. Aust N Z J Psychiatry. 2023. PMID: 35920236 No abstract available.
Abstract
Despite more than 25 years of research establishing the antidepressant efficacy of repetitive transcranial magnetic stimulation, there remains uncertainty about the depth and breadth of this evidence base, resulting in confusion as to where repetitive transcranial magnetic stimulation fits in the therapeutic armamentarium in the management of patients with mood disorders. The purpose of this article is to provide a concise description of the evidence base supporting the use of repetitive transcranial magnetic stimulation in the context of the stages of research that typically accompanies the development of evidence for a new therapy. The antidepressant efficacy for the use of repetitive transcranial magnetic stimulation in the treatment of depression has been established through a relatively traditional pathway beginning with small case series, progressing to single-site clinical trials and then to larger multisite randomised double-blind controlled trials. Antidepressant effects have been confirmed in numerous meta-analyses followed more recently by large network meta-analysis and umbrella reviews, with evidence that repetitive transcranial magnetic stimulation may have greater efficacy than alternatives for patients with treatment-resistant depression. Finally, repetitive transcranial magnetic stimulation has been shown to produce meaningful response and remission rates in real-world samples of greater than 5000 patients. The evidence for the antidepressant efficacy of repetitive transcranial magnetic stimulation therapy is overwhelming, and it should be considered a routine part of clinical care wherever available.
Keywords: Repetitive transcranial magnetic stimulation; clinical practice guidelines; depression; evidence; guidelines; mood disorders; response.
Similar articles
-
Efficacy of repetitive transcranial magnetic stimulation (rTMS) adjunctive therapy for major depressive disorder (MDD) after two antidepressant treatment failures: meta-analysis of randomized sham-controlled trials.BMC Psychiatry. 2023 Jul 27;23(1):545. doi: 10.1186/s12888-023-05033-y. BMC Psychiatry. 2023. PMID: 37501135 Free PMC article.
-
A clinical repetitive transcranial magnetic stimulation service in Australia: 6 years on.Aust N Z J Psychiatry. 2015 Nov;49(11):1040-7. doi: 10.1177/0004867415607985. Aust N Z J Psychiatry. 2015. PMID: 26508800
-
Revisiting the effectiveness of repetitive transcranial magnetic stimulation treatment in depression, again.Aust N Z J Psychiatry. 2022 Aug;56(8):905-909. doi: 10.1177/00048674211068788. Epub 2021 Dec 30. Aust N Z J Psychiatry. 2022. PMID: 34969310
-
Durability of the antidepressant effect of the high-frequency repetitive transcranial magnetic stimulation (rTMS) In the absence of maintenance treatment in major depression: a systematic review and meta-analysis of 16 double-blind, randomized, sham-controlled trials.Depress Anxiety. 2015 Mar;32(3):193-203. doi: 10.1002/da.22339. Epub 2015 Feb 13. Depress Anxiety. 2015. PMID: 25683231 Review.
-
[Toward the Introduction of Repetitive Transcranial Magnetic Stimulation in Japan to Treat Antidepressant-resistant Depression].Seishin Shinkeigaku Zasshi. 2015;117(2):120-5. Seishin Shinkeigaku Zasshi. 2015. PMID: 26514051 Review. Japanese.
Cited by
-
Never Too Late: Safety and Efficacy of Deep TMS for Late-Life Depression.J Clin Med. 2024 Jan 31;13(3):816. doi: 10.3390/jcm13030816. J Clin Med. 2024. PMID: 38337509 Free PMC article.
-
10 Hz repetitive transcranial magnetic stimulation (rTMS) may improve cognitive function: An exploratory study of schizophrenia patients with auditory hallucinations.Heliyon. 2023 Sep 9;9(9):e19912. doi: 10.1016/j.heliyon.2023.e19912. eCollection 2023 Sep. Heliyon. 2023. PMID: 37809845 Free PMC article.
-
Accelerated Repetitive Transcranial Magnetic Stimulation to Treat Major Depression: The Past, Present, and Future.Harv Rev Psychiatry. 2023 May-Jun 01;31(3):142-161. doi: 10.1097/HRP.0000000000000364. Harv Rev Psychiatry. 2023. PMID: 37171474 Free PMC article.
-
Medicare Benefits Schedule item numbers for transcranial magnetic stimulation (TMS): Questions arising.Australas Psychiatry. 2023 Aug;31(4):494-496. doi: 10.1177/10398562231173228. Epub 2023 May 2. Australas Psychiatry. 2023. PMID: 37128938 Free PMC article.
-
Current Status of Neuromodulation-Induced Cortical Prehabilitation and Considerations for Treatment Pathways in Lower-Grade Glioma Surgery.Life (Basel). 2022 Mar 22;12(4):466. doi: 10.3390/life12040466. Life (Basel). 2022. PMID: 35454957 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical